$PPT-The Biology of Relapsed and Refractory Multiple Myeloma$

PPT-The Biology of Relapsed and Refractory Multiple Myeloma

Author : alexa-scheidler | Published Date : 2016-07-01

Topics Current Treatment Options for RelapsedRefractory Multiple Myeloma Topics RelapsedRefractory MM Treatment Goals and Strategies RelapsedRefractory MM Exposure

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "The Biology of Relapsed and Refractory M..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

The Biology of Relapsed and Refractory Multiple Myeloma: Transcript

Topics Current Treatment Options for RelapsedRefractory Multiple Myeloma Topics RelapsedRefractory MM Treatment Goals and Strategies RelapsedRefractory MM Exposure to Stem Cell Toxic Agents Not An Issue for Most Patients . Dr. Andrew Chantry. Senior Clinical Lecturer and Honorary Consultant in . Haematology. University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. UKMF Autumn Educational Day ‘The evolving management of multiple myeloma and related plasma cell disorders’. 5 Multiple Myeloma SANDRA E. KURTIN, RN, MS, AOCN Ruben Niesvizky. Myeloma Center. Myelomacenter.org. run9001@med.cornell.edu. Multiple Myeloma: Natural History of Disease. Durie B; International Myeloma Foundation. . Concise review of the disease and treatment options: multiple myeloma. 2011/2012 edition;. Hodgkin Lymphoma. Program Objectives. Brentuximab Vedotin in Hodgkin Lymphoma. Brentuximab Vedotin in Patients With R/R HL. Brentuximab Vedotin: Adverse Events . Nivolumab in Relapsed/Refractory HL. Pembrolizumab in Relapsed/Refractory HL. therapy in relapsed/refractory myeloma: . A UK multi-centre experience. Neil Rabin. Consultant Haematologist. o. n behalf of Dr Nicola . Maciocia. University College London Hospitals, UK. 4. th. November 2015. Program Goals. Defining Multiple Myeloma. Case 1. Diagnostic Criteria. Multiple Myeloma Requiring Therapy. Cytogenetic Risk Features. Case 1 (cont). Newly Diagnosed Multiple Myeloma. NCCN. ®. . Therapy for Transplant-Eligible Patients. Case Discussion A 64-year old woman diagnosed with monoclonal gammopathy of undetermined significance (MGUS ) in September 2015 She has been monitored over time and has had a slight increase in her proteins. Bertrand Coiffier. Service d. ’. Hématologie. Hospices Civils de Lyon. Equipe . « Pathologie des Cellules Lymphoïdes ». UMR 5239 CNRS – UCB – ENS - HCL. The Lymphoma. Study Association. One question, lot of possibilities. Part I: Smoldering Multiple Myeloma . and . Induction Therapy for Patients with Newly Diagnosed Multiple Myeloma . Moderator: . Sagar. . Lonial. , MD. Panelists: . Jonathan Kaufman, MD and Ajay . Nooka. Vi Dao, MD, FRCPC. vdao@cancercare.mb.ca. Presenter Disclosure. Faculty: Vi Dao. Relationships with commercial interests: none. Mitigating Potential Bias. Not Applicable. Learning Objectives. Distinguish MGUS from multiple myeloma. Myelom. Heinz . Gisslinger. Medizinische Universität Wien. . Medizinische . Universität Wien. Die häufigsten Tumorlokalisationen nach Geschlecht (2014). . 20.361 Männer = 100% 18.547 Frauen = 100%. How to treat. triple- or penta-refractory . Multiple Myeloma?. María-Victoria . Mateos. , MD, PhD. University Hospital of Salamanca-. Ibsal. . Salamanca, Spain. 2. This . LYMPHOMA & MYELOMA CONNECT . Grace B. Athas, Ph.D. . MLS. Department of pathology, LSUHSC. CLPC Spring seminar series, 2018 . Learning objectives. Review pathophysiology and lab diagnosis of plasma cell neoplasms with a focus on Multiple Myeloma. IMW | SOHO | SOHO Italy. Dr.. Claudio . Cerchione. , MD, PhD. Istituto. . Scientifico. Romagnolo per lo Studio e la . Cura. . dei. . Tumori. IRCCS. Meldola. , Italy. HIGHLIGHTS FROM LYMPHOMA & MYELOMA CONNECT.

Download Document

Here is the link to download the presentation.
"The Biology of Relapsed and Refractory Multiple Myeloma"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.